Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (707)	2/28/2005 3:35:48 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 3722

One month later, my stock has pulled above some moving averages...but at the moment GLGC is down a dime to $3.17-- following the entire biotech group down. A CC is scheduled for March 17th, and that should illuminate where this is going to go. They have launched a software product "ToxShield Suite" in the past month and held their 4th quarter call: Ended the year with 103M and burned 4M last quarter. The marketcap right now is 101M. Directors and CEO are giving themselves a gravy incentive plan. I am off 8% in this stock at the moment and feel pretty comfortable holding it. I think it is worth looking at, especially as we draw closer to the March call. Also, I noted Perlegen raised a nice chunk of change today.